<DOC>
	<DOCNO>NCT03081637</DOCNO>
	<brief_summary>The risk recurrence hepatectomy hepatocellular carcinoma ( HCC ) high . Having predictive marker early recurrence ( ER ) would desirable personalize follow-up possibly develop new target therapy . The aim study test expression Filamin A ( FLNA ) cohort patient operate HCC .</brief_summary>
	<brief_title>FLNA HCC Patients</brief_title>
	<detailed_description>A consecutive cohort resect HCC patient analyze . Several different prognostic factor , include FLNA expression , test risk ER . FLNA expression analyze immunohistochemistry intra-tumoral extra-tumoral tissue compartment use dedicated tissue microarray .</detailed_description>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>The inclusion criterion represent histological positivity HCC complete clinical , surgical , pathological , followup data . Patients preoperatively treat chemotherapy transarterial therapy exclude . Similarly , patient operate recurrent HCC nonradical surgery miss data exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>